The weekly litigation news digest is live. Subscribe now

IP Verse

Predicting Outcome Of Treatment With An Anti- 4 7 Integrin Antibody - EP3237004

The patent EP3237004 was granted to Millennium Pharmaceuticals on May 8, 2024. The application was filed on Dec 23, 2015 under application number EP15873834A. The patent is currently recorded with a legal status of "Revoked".

EP3237004

MILLENNIUM PHARMACEUTICALS
Application Number
EP15873834A
Filing Date
Dec 23, 2015
Status
Revoked
Aug 15, 2025
Publication Date
May 8, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
POLPHARMA BIOLOGICSFeb 7, 2025SIMMONS & SIMMONS MUNICHADMISSIBLE

Patent Citations (13) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2005095238
DESCRIPTIONUS2012282249
DESCRIPTIONUS2014120084
DESCRIPTIONUS4816567
DESCRIPTIONUS6197582
DESCRIPTIONUS7803904
DESCRIPTIONWO2012135589
DESCRIPTIONWO2012151247
DESCRIPTIONWO2012151248
DESCRIPTIONWO9624673
INTERNATIONAL-SEARCH-REPORTUS2014120084
SEARCHUS2012282249
SEARCHWO2012135589

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents